News - See what's new!
Find all the latest information on upcoming events, product developments, and company announcements.
Novel fluorescence lifetime imaging may complement BluePeak for prediction of progression in Stargardt disease
Since its introduction, BluePeak blue laser autofluorescence has become a widely established scanning laser fundus imaging modality to provide a map of the retina which can reveal metabolic malfunction of diagnostic significance in many conditions.Read more
The following article written by Prof. Dr. Frank G. Holz, published in The Ophthalmologist will take you on "a journey from pencil drawings of retinal pathology to fluorescence lifetime imaging ophthalmoscopy."Read more
Cincinnati Eye Institute (CEI) Workflow Study: Adding a SPECTRALIS OCT System shortens overall patient processing time by 27% or more
Daniel Miller, MD, Matthew Dressler, and Darlene Casbar conducted the Cincinnati Eye Workflow Study over the course of six weeks.Read more
The European Glaucoma Society (EGS) Meeting in Prague is just around the corner, and Heidelberg Engineering will be part of that exciting meeting. We are pleased to invite you to join us for the Heidelberg Engineering Industry Meeting.Read more
The following article written by S.K. Steven Houston III, MD published in Retina Today provides a comprehensive review on the OCT features and functions.Read more
OCT angiography (OCT-A) is an emerging imaging modality with the potential to enhance the diagnostic understanding of various disease entities. It offers the possibility to visualize vascular networks in high-resolution and non-invasively as opposed to established imaging methods such as FA and ICGA angiography.Read more
The introduction of OCT technology puts powerful diagnostic capabilities in the hands of eye care professionals. In particular, for many diseases, general ophthalmologists and optometrists can now make diagnoses right in their own practice [...]Read more